Annual Cash & Cash Equivalents
$3.20 M
+$2.56 M+396.59%
31 December 2023
Summary:
Kiromic BioPharma annual cash & cash equivalents is currently $3.20 million, with the most recent change of +$2.56 million (+396.59%) on 31 December 2023. During the last 3 years, it has fallen by -$6.95 million (-68.44%). KRBP annual cash & cash equivalents is now -87.36% below its all-time high of $25.35 million, reached on 31 December 2021.KRBP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.92 M
-$1.12 M-27.77%
30 September 2024
Summary:
Kiromic BioPharma quarterly cash and cash equivalents is currently $2.92 million, with the most recent change of -$1.12 million (-27.77%) on 30 September 2024. Over the past year, it has dropped by -$1.46 million (-33.23%). KRBP quarterly cash and cash equivalents is now -91.68% below its all-time high of $35.16 million, reached on 30 September 2021.KRBP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRBP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +396.6% | -33.2% |
| 3 y3 years | -68.4% | -91.7% |
| 5 y5 years | +733.7% | - |
KRBP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.4% | +396.6% | -91.7% | +575.8% |
| 5 y | 5 years | -87.4% | +733.7% | -91.7% | +575.8% |
| alltime | all time | -87.4% | +733.7% | -91.7% | +575.8% |
Kiromic BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.92 M(-27.8%) |
| June 2024 | - | $4.05 M(+10.1%) |
| Mar 2024 | - | $3.68 M(+14.7%) |
| Dec 2023 | $3.20 M(+396.6%) | $3.20 M(-26.8%) |
| Sept 2023 | - | $4.38 M(+62.0%) |
| June 2023 | - | $2.70 M(+31.6%) |
| Mar 2023 | - | $2.05 M(+218.4%) |
| Dec 2022 | $645.20 K | $645.20 K(+49.1%) |
| Sept 2022 | - | $432.70 K(-93.4%) |
| June 2022 | - | $6.51 M(-56.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $15.12 M(-40.4%) |
| Dec 2021 | $25.35 M(+149.8%) | $25.35 M(-27.9%) |
| Sept 2021 | - | $35.16 M(+1045.2%) |
| June 2021 | - | $3.07 M(-58.1%) |
| Mar 2021 | - | $7.34 M(-27.7%) |
| Dec 2020 | $10.15 M(+426.2%) | $10.15 M(+2062.9%) |
| Sept 2020 | - | $469.30 K(-72.1%) |
| June 2020 | - | $1.68 M(-44.7%) |
| Mar 2020 | - | $3.04 M(+57.7%) |
| Dec 2019 | $1.93 M(+402.0%) | $1.93 M |
| Dec 2018 | $384.30 K | - |
FAQ
- What is Kiromic BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kiromic BioPharma?
- What is Kiromic BioPharma annual cash & cash equivalents year-on-year change?
- What is Kiromic BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly cash and cash equivalents year-on-year change?
What is Kiromic BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of KRBP is $3.20 M
What is the all time high annual cash & cash equivalents for Kiromic BioPharma?
Kiromic BioPharma all-time high annual cash & cash equivalents is $25.35 M
What is Kiromic BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, KRBP annual cash & cash equivalents has changed by +$2.56 M (+396.59%)
What is Kiromic BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KRBP is $2.92 M
What is the all time high quarterly cash and cash equivalents for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly cash and cash equivalents is $35.16 M
What is Kiromic BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, KRBP quarterly cash and cash equivalents has changed by -$1.46 M (-33.23%)